Change from baseline to week 4 in HDL-C levels between the Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2, and Nut-Free Diet
The change from baseline in HDL-C levels at week 4 between Almond-enriched Diet Dose 1 (AD1), Almond-Enriched Diet Dose 2 (AD2), and Nut-Free Diet (NFD) will be determined.
Change from baseline to week 8 in HDL-C levels between the Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2, and Nut-Free Diet
The change from baseline in HDL-C levels at week 8 between Almond-enriched Diet Dose 1 (AD1), Almond-Enriched Diet Dose 2 (AD2), and Nut-Free Diet (NFD) will be determined.
Change from baseline to week 12 in HDL-C levels between the Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2, and Nut-Free Diet
The change from baseline in HDL-C levels at week 12 between Almond-enriched Diet Dose 1 (AD1), Almond-Enriched Diet Dose 2 (AD2), and Nut-Free Diet (NFD) will be determined.
The difference in the proportion of participants from baseline to 4 weeks achieving a clinically relevant increase in HDL-C levels
The difference in the proportion of participants from baseline to 4 weeks achieving a clinically relevant increase in HDL-C levels defined as an increase of at least 1 mg/dL (0.026 mmol/L) will be determined.
The difference in the proportion of participants from baseline to 8 weeks achieving a clinically relevant increase in HDL-C levels
The difference in the proportion of participants from baseline to 8 weeks achieving a clinically relevant increase in HDL-C levels defined as an increase of at least 1 mg/dL (0.026 mmol/L) will be determined.
The difference in the proportion of participants from baseline to 12 weeks achieving a clinically relevant increase in HDL-C levels
The difference in the proportion of participants from baseline to 12 weeks achieving a clinically relevant increase in HDL-C levels defined as an increase of at least 1 mg/dL (0.026 mmol/L) will be determined.
The difference in the proportion of participants from baseline to 16 weeks achieving a clinically relevant increase in HDL-C levels
The difference in the proportion of participants from baseline to 16 weeks achieving a clinically relevant increase in HDL-C levels defined as an increase of at least 1 mg/dL (0.026 mmol/L) will be determined.
The difference in the proportion of participants from baseline to 16 weeks achieving no change or an increase in HDL-C levels
The difference in the proportion of participants from baseline to 16 weeks achieving no change or an increase in HDL-C levels based on expected effects through almond intervention will be determined.
The difference in the proportion of participants from baseline to 4 weeks achieving no change or an increase in HDL-C levels
The difference in the proportion of participants from baseline to 4 weeks achieving no change or an increase in HDL-C levels based on expected effects through almond intervention will be determined.
The difference in the proportion of participants from baseline to 8 weeks achieving no change or an increase in HDL-C levels
The difference in the proportion of participants from baseline to 8 weeks achieving no change or an increase in HDL-C levels based on expected effects through almond intervention will be determined.
The difference in the proportion of participants from baseline to 12 weeks achieving no change or an increase in HDL-C levels
The difference in the proportion of participants from baseline to 12 weeks achieving no change or an increase in HDL-C levels based on expected effects through almond intervention will be determined.
The difference in the proportion of participants from baseline to 4 weeks achieving movement from HDL-C categories
The difference in the proportion of participants from baseline to 4 weeks achieving movement from HDL-C categories defined by NCEP guidelines (those with HDL-C levels <40 mg/dL (1.04 mmol/L) and ≥40 mg/dL) will be determined.
The difference in the proportion of participants from baseline to 8 weeks achieving movement from HDL-C categories
The difference in the proportion of participants from baseline to 8 weeks achieving movement from HDL-C categories defined by NCEP guidelines (those with HDL-C levels <40 mg/dL (1.04 mmol/L) and ≥40 mg/dL) will be determined.
The difference in the proportion of participants from baseline to 12 weeks achieving movement from HDL-C categories
The difference in the proportion of participants from baseline to 12 weeks achieving movement from HDL-C categories defined by NCEP guidelines (those with HDL-C levels <40 mg/dL (1.04 mmol/L) and ≥40 mg/dL) will be determined.
The difference in the proportion of participants from baseline to 16 weeks achieving movement from HDL-C categories
The difference in the proportion of participants from baseline to 16 weeks achieving movement from HDL-C categories defined by NCEP guidelines (those with HDL-C levels <40 mg/dL (1.04 mmol/L) and ≥40 mg/dL) will be determined.
The difference in the proportion of participants from baseline to 16 weeks achieving a change in total cholesterol levels
The difference in the proportion of participants from baseline to 16 weeks achieving a change in total cholesterol levels will be determined.
The difference in the proportion of participants from baseline to 4 weeks achieving a change in total cholesterol levels
The difference in the proportion of participants from baseline to 4 weeks achieving a change in total cholesterol levels will be determined.
The difference in the proportion of participants from baseline to 8 weeks achieving a change in total cholesterol levels
The difference in the proportion of participants from baseline to 8 weeks achieving a change in total cholesterol levels will be determined.
The difference in the proportion of participants from baseline to 12 weeks achieving a change in total cholesterol levels
The difference in the proportion of participants from baseline to 12 weeks achieving a change in total cholesterol levels will be determined.
The difference in the proportion of participants from baseline to 4 weeks achieving a change in LDL-C levels
The difference in the proportion of participants from baseline to 4 weeks achieving a change in LDL-C levels will be determined.
The difference in the proportion of participants from baseline to 12 weeks achieving a change in LDL-C levels
The difference in the proportion of participants from baseline to 12 weeks achieving a change in LDL-C levels will be determined.
The difference in the proportion of participants from baseline to 16 weeks achieving a change in LDL-C levels
The difference in the proportion of participants from baseline to 16 weeks achieving a change in LDL-C levels will be determined.
The difference in the proportion of participants from baseline to 8 weeks achieving a change in LDL-C levels
The difference in the proportion of participants from baseline to 8 weeks achieving a change in LDL-C levels will be determined.
The difference in the proportion of participants from baseline to 4 weeks achieving a change in triglyceride levels
The difference in the proportion of participants from baseline to 4 weeks achieving a change in triglyceride levels will be determined.
The difference in the proportion of participants from baseline to 8 weeks achieving a change in triglyceride levels
The difference in the proportion of participants from baseline to 8 weeks achieving a change in triglyceride levels will be determined.
The difference in the proportion of participants from baseline to 12 weeks achieving a change in triglyceride levels
The difference in the proportion of participants from baseline to 12 weeks achieving a change in triglyceride levels will be determined.
The difference in the proportion of participants from baseline to 16 weeks achieving a change in triglyceride levels
The difference in the proportion of participants from baseline to 16 weeks achieving a change in triglyceride levels will be determined.
The difference in the proportion of participants from baseline to 4 weeks achieving a change in non-HDL-C levels
The difference in the proportion of participants from baseline to 4 weeks achieving a change in non-HDL-C levels will be determined.
The difference in the proportion of participants from baseline to 8 weeks achieving a change in non-HDL-C levels
The difference in the proportion of participants from baseline to 8 weeks achieving a change in non-HDL-C levels will be determined.
The difference in the proportion of participants from baseline to 12 weeks achieving a change in non-HDL-C levels
The difference in the proportion of participants from baseline to 12 weeks achieving a change in non-HDL-C levels will be determined.
The difference in the proportion of participants from baseline to 16 weeks achieving a change in non-HDL-C levels
The difference in the proportion of participants from baseline to 16 weeks achieving a change in non-HDL-C levels will be determined.
The difference in the proportion of participants from baseline to 4 weeks achieving a change in the Triglyceride/HDL-C ratio
The difference in the proportion of participants from baseline to 4 weeks achieving a change in the Triglyceride/HDL-C ratio will be determined.
The difference in the proportion of participants from baseline to 8 weeks achieving a change in the Triglyceride/HDL-C ratio
The difference in the proportion of participants from baseline to 8 weeks achieving a change in the Triglyceride/HDL-C ratio will be determined.
The difference in the proportion of participants from baseline to 12 weeks achieving a change in the Triglyceride/HDL-C ratio
The difference in the proportion of participants from baseline to 12 weeks achieving a change in the Triglyceride/HDL-C ratio will be determined.
The difference in the proportion of participants from baseline to 16 weeks achieving a change in the Triglyceride/HDL-C ratio
The difference in the proportion of participants from baseline to 16 weeks achieving a change in the Triglyceride/HDL-C ratio will be determined.
The difference in the proportion of participants from baseline to 4 weeks achieving a change in the Total Cholesterol/HDL-C ratio
The difference in the proportion of participants from baseline to 4 weeks achieving a change in the Total Cholesterol/HDL-C ratio will be determined.
The difference in the proportion of participants from baseline to 8 weeks achieving a change in the Total Cholesterol/HDL-C ratio
The difference in the proportion of participants from baseline to 8 weeks achieving a change in the Total Cholesterol/HDL-C ratio will be determined.
The difference in the proportion of participants from baseline to 12 weeks achieving a change in the Total Cholesterol/HDL-C ratio
The difference in the proportion of participants from baseline to 12 weeks achieving a change in the Total Cholesterol/HDL-C ratio will be determined.
The difference in the proportion of participants from baseline to 16 weeks achieving a change in the Total Cholesterol/HDL-C ratio
The difference in the proportion of participants from baseline to 16 weeks achieving a change in the Total Cholesterol/HDL-C ratio will be determined.
The difference in the proportion of participants from baseline to 4 weeks achieving a change in the LDL-C/HDL-C ratio
The difference in the proportion of participants from baseline to 4 weeks achieving a change in the LDL-C/HDL-C ratio will be determined.
The difference in the proportion of participants from baseline to 8 weeks achieving a change in the LDL-C/HDL-C ratio
The difference in the proportion of participants from baseline to 8 weeks achieving a change in the LDL-C/HDL-C ratio will be determined.
The difference in the proportion of participants from baseline to 12 weeks achieving a change in the LDL-C/HDL-C ratio
The difference in the proportion of participants from baseline to 12 weeks achieving a change in the LDL-C/HDL-C ratio will be determined.
The difference in the proportion of participants from baseline to 16 weeks achieving a change in the LDL-C/HDL-C ratio
The difference in the proportion of participants from baseline to 16 weeks achieving a change in the LDL-C/HDL-C ratio will be determined.
The difference in change in ApoB48 concentration between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 8 weeks
The difference in change in ApoB48 concentration between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 8 weeks will be determined.
The difference in change in ApoB48 concentration between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 16 weeks
The difference in change in ApoB48 concentration between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 16 weeks will be determined.
The difference in change in ApoB100 concentration between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 16 weeks
The difference in change in ApoB100 concentration between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 16 weeks will be determined.
The difference in change in ApoB100 concentration between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 8 weeks
The difference in change in ApoB100 concentration between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 8 weeks will be determined.
The difference in change in cardiovascular disease risk between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 8 weeks
The difference in change in cardiovascular disease (CVD) risk between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 8 weeks will be determined. Cardiovascular disease risk scores will be assessed by Framingham CVD Risk Scores, which is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual.
The difference in change in cardiovascular disease risk between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 16 weeks
The difference in change in cardiovascular disease (CVD) risk between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet from baseline to 16 weeks will be determined. Cardiovascular disease risk scores will be assessed by Framingham CVD Risk Scores, which is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual.
The change in weight from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in weight from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in weight from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in weight from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in weight from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in weight from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in weight from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in weight from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in Body Mass Index from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Body Mass Index from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in Body Mass Index from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Body Mass Index from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in Body Mass Index from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Body Mass Index from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in Body Mass Index from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Body Mass Index from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in Sagittal Abdominal Diameter from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Sagittal Abdominal Diameter from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined. Also known as abdominal height, Sagittal Abdominal Diameter will be measured with the participant in a supine position with straight legs after normal expiration. At the level of the iliac crest, Sagittal Abdominal Diameter is the distance between the examination table to the horizontal level using abdominal calipers. At least two separate measurements are to be taken at each visit. If the two measurements differ by more than 0.5 cm, a third measurement is to be taken and the two closest values will be averaged for final measurement.
The change in Sagittal Abdominal Diameter from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Sagittal Abdominal Diameter from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined. Also known as abdominal height, Sagittal Abdominal Diameter will be measured with the participant in a supine position with straight legs after normal expiration. At the level of the iliac crest, Sagittal Abdominal Diameter is the distance between the examination table to the horizontal level using abdominal calipers. At least two separate measurements are to be taken at each visit. If the two measurements differ by more than 0.5 cm, a third measurement is to be taken and the two closest values will be averaged for final measurement.
The change in Sagittal Abdominal Diameter from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Sagittal Abdominal Diameter from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined. Also known as abdominal height, Sagittal Abdominal Diameter will be measured with the participant in a supine position with straight legs after normal expiration. At the level of the iliac crest, Sagittal Abdominal Diameter is the distance between the examination table to the horizontal level using abdominal calipers. At least two separate measurements are to be taken at each visit. If the two measurements differ by more than 0.5 cm, a third measurement is to be taken and the two closest values will be averaged for final measurement.
The change in Sagittal Abdominal Diameter from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Sagittal Abdominal Diameter from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined. Also known as abdominal height, Sagittal Abdominal Diameter will be measured with the participant in a supine position with straight legs after normal expiration. At the level of the iliac crest, Sagittal Abdominal Diameter is the distance between the examination table to the horizontal level using abdominal calipers. At least two separate measurements are to be taken at each visit. If the two measurements differ by more than 0.5 cm, a third measurement is to be taken and the two closest values will be averaged for final measurement.
The change in Waist Circumference from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Waist Circumference from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined. Measurements will be performed when standing at the part of the trunk located midway between the lower costal margin and the iliac crest. At least two separate measurements are to be taken at each visit. If the two measurements differ by more than 10%, a third measurement is to be taken and the two closest values will be averaged for final measurement. The height of the waist will be also recorded at baseline, and then used to determine the waist throughout the study in order to ensure a consistent measurement at all visits.
The change in Waist Circumference from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Waist Circumference from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined. Measurements will be performed when standing at the part of the trunk located midway between the lower costal margin and the iliac crest. At least two separate measurements are to be taken at each visit. If the two measurements differ by more than 10%, a third measurement is to be taken and the two closest values will be averaged for final measurement. The height of the waist will be also recorded at baseline, and then used to determine the waist throughout the study in order to ensure a consistent measurement at all visits.
The change in Waist Circumference from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Waist Circumference from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined. Measurements will be performed when standing at the part of the trunk located midway between the lower costal margin and the iliac crest. At least two separate measurements are to be taken at each visit. If the two measurements differ by more than 10%, a third measurement is to be taken and the two closest values will be averaged for final measurement. The height of the waist will be also recorded at baseline, and then used to determine the waist throughout the study in order to ensure a consistent measurement at all visits.
The change in Waist Circumference from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Waist Circumference from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined. Measurements will be performed when standing at the part of the trunk located midway between the lower costal margin and the iliac crest. At least two separate measurements are to be taken at each visit. If the two measurements differ by more than 10%, a third measurement is to be taken and the two closest values will be averaged for final measurement. The height of the waist will be also recorded at baseline, and then used to determine the waist throughout the study in order to ensure a consistent measurement at all visits.
The change in Waist to Hip Ratio from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Waist to Hip Ratio from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in Waist to Hip Ratio from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Waist to Hip Ratio from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in Waist to Hip Ratio from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Waist to Hip Ratio from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in Waist to Hip Ratio from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in Waist to Hip Ratio from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in blood pressure from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in blood pressure from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in blood pressure from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in blood pressure from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in blood pressure from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in blood pressure from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The change in blood pressure from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet
The change in blood pressure from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The difference in change in serum α-tocopherol concentrations from baseline to 16 weeks between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet
The difference in change in serum α-tocopherol concentrations from baseline to 16 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The difference in change in serum α-tocopherol concentrations from baseline to 12 weeks between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet
The difference in change in serum α-tocopherol concentrations from baseline to 12 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The difference in change in serum α-tocopherol concentrations from baseline to 8 weeks between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet
The difference in change in serum α-tocopherol concentrations from baseline to 8 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.
The difference in change in serum α-tocopherol concentrations from baseline to 4 weeks between Almond-enriched Diet Dose 1 and Almond-Enriched Diet Dose 2 compared to the Nut-Free Diet
The difference in change in serum α-tocopherol concentrations from baseline to 4 weeks between Almond-enriched Diet Dose 1, Almond-Enriched Diet Dose 2 and the Nut-Free Diet will be determined.